表紙
市場調査レポート

北米における心血管モニタリングおよび診断装置市場の見通し

North America Cardiovascular Monitoring and Diagnostic Devices Market Outlook to 2020

発行 GlobalData 商品コード 304022
出版日 ページ情報 英文 150 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.39円で換算しております。
Back to Top
北米における心血管モニタリングおよび診断装置市場の見通し North America Cardiovascular Monitoring and Diagnostic Devices Market Outlook to 2020
出版日: 2014年05月16日 ページ情報: 英文 150 Pages
概要

当レポートでは、北米における心血管モニタリングおよび診断装置市場について、心肺負荷テストシステム、心電図データ管理システム、心電図モニタリング装置、負荷心電図検査システム、イベントモニタリングシステム、ホルター心電計のカテゴリー別売上、販売数の実績および予測、平均価格、企業シェア、流通シェア、主要企業のプロファイル、パイプライン製品、主な財務取引についての最新情報などをまとめており、提供しています。

第1章 目次

第2章 イントロダクション

  • レポートの内容
  • 心血管モニタリングおよび診断装置市場の区分
  • 本レポートで対象としている市場の定義

第3章 北米における心血管モニタリングおよび診断装置市場

  • 収益(実績・予測)
  • 収益別カテゴリー比較(実績・予測)
  • 収益(実績)
  • 収益(予測)
  • 販売数(実績・予測)
  • 販売数(実績)
  • 販売数(予測)
  • 企業シェア:収益別

第4章 カナダにおける心血管モニタリングおよび診断装置市場

  • 収益(実績)
  • 収益(予測)
  • 販売数(実績)
  • 販売数(予測)
  • 平均価格
  • 流通シェア:収益別
  • 企業シェア:収益別

第5章 メキシコにおける心血管モニタリングおよび診断装置市場

  • 収益(実績)
  • 収益(予測)
  • 販売数(実績)
  • 販売数(予測)
  • 平均価格
  • 流通シェア:収益別
  • 企業シェア:収益別

第6章 米国における心血管モニタリングおよび診断装置市場

  • 収益(実績)
  • 収益(予測)
  • 販売数(実績)
  • 販売数(予測)
  • 平均価格
  • 流通シェア:収益別
  • 企業シェア:収益別

第7章 主要企業の概要

  • GE Healthcare
  • Philips Healthcare
  • CareFusion Corporation
  • Welch Allyn Inc. OSI Systems, Inc.
  • OSI Systems, Inc.
  • Opto Circuits India Limited
  • Schiller AG
  • Mortara Instrument, Inc.
  • 日本光電
  • フクダ電子

第8章 パイプライン製品

第9章 最新の動向

  • コーポレート・コミュニケーション
  • 財務発表
  • 政府・公益関連情報
  • 法規制
  • 他の重要な動向
  • 製品情報
  • 研究開発
  • 戦略および事業企画

第10章 付録

図表

目次
Product Code: GDMECR0091DB

GlobalData's new report, "North America Cardiovascular Monitoring and Diagnostic Devices Market Outlook to 2020", provides key market data on the North America Cardiovascular Monitoring and Diagnostic Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testing Systems, Event Monitoring Systems and Holter Monitoring Systems.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiovascular Monitoring and Diagnostic Devices market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Cardiovascular Monitoring and Diagnostic Devices categories - Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testing Systems, Event Monitoring Systems and Holter Monitoring Systems.
  • Annualized market revenue (USD million), volume (units) and average selling price ($) data for the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
  • 2012 company shares and distribution shares data for the market category.
  • Global corporate-level profiles of key companies operating within the North America Cardiovascular Monitoring and Diagnostic Devices market.
  • Key players covered include GE Healthcare, Philips Healthcare, Welch Allyn Inc., OSI Systems, Inc., CareFusion Corporation, Cardiac Science Corporation, Schiller AG and Card Guard Scientific Survival, Ltd.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Cardiovascular Monitoring and Diagnostic Devices Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Cardiovascular Monitoring and Diagnostic Devices Market, North America

  • 3.1. Cardiovascular Monitoring and Diagnostic Devices Market, North America, Revenue ($m), 2005-2020
  • 3.2. Cardiovascular Monitoring and Diagnostic Devices Market, North America, Category Comparison by Revenue ($m), 2005-2020
  • 3.3. Cardiovascular Monitoring and Diagnostic Devices Market, North America, Revenue ($m), 2005-2012
  • 3.4. Cardiovascular Monitoring and Diagnostic Devices Market, North America, Revenue ($m), 2012-2020
  • 3.5. Cardiovascular Monitoring and Diagnostic Devices Market, North America, Volume (Units), 2005-2020
  • 3.6. Cardiovascular Monitoring and Diagnostic Devices Market, North America, Volume (Units), 2005-2012
  • 3.7. Cardiovascular Monitoring and Diagnostic Devices Market, North America, Volume (Units), 2012-2020
  • 3.8. Cardiovascular Monitoring and Diagnostic Devices Market, North America, Company Share by Revenue ($m), 2011-2012

4. Cardiovascular Monitoring and Diagnostic Devices Market, Canada

  • 4.1. Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Revenue ($m), 2005-2012
  • 4.2. Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Revenue ($m), 2012-2020
  • 4.3. Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Volume (Units), 2005-2012
  • 4.4. Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Volume (Units), 2012-2020
  • 4.5. Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Average Price ($), 2005-2020
  • 4.6. Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Distribution Share by Revenue ($m), 2011-2012
  • 4.7. Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Company Share by Revenue ($m), 2011-2012

5. Cardiovascular Monitoring and Diagnostic Devices Market, Mexico

  • 5.1. Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Revenue ($m), 2005-2012
  • 5.2. Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Revenue ($m), 2012-2020
  • 5.3. Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Volume (Units), 2005-2012
  • 5.4. Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Volume (Units), 2012-2020
  • 5.5. Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Average Price ($), 2005-2020
  • 5.6. Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Distribution Share by Revenue ($m), 2011-2012
  • 5.7. Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Company Share by Revenue ($m), 2011-2012

6. Cardiovascular Monitoring and Diagnostic Devices Market, United States

  • 6.1. Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), 2005-2012
  • 6.2. Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), 2012-2020
  • 6.3. Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), 2005-2012
  • 6.4. Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), 2012-2020
  • 6.5. Cardiovascular Monitoring and Diagnostic Devices Market, United States, Average Price ($), 2005-2020
  • 6.6. Cardiovascular Monitoring and Diagnostic Devices Market, United States, Distribution Share by Revenue ($m), 2011-2012
  • 6.7. Cardiovascular Monitoring and Diagnostic Devices Market, United States, Company Share by Revenue ($m), 2011-2012

7. Overview of Key Companies in North America Cardiovascular Monitoring and Diagnostic Devices Market

  • 7.1. GE Healthcare
    • 7.1.1. Company Overview
  • 7.2. Philips Healthcare
    • 7.2.1. Company Overview
  • 7.3. CareFusion Corporation
    • 7.3.1. Company Overview
  • 7.4. Welch Allyn Inc.
    • 7.4.1. Company Overview
  • 7.5. OSI Systems, Inc.
    • 7.5.1. Company Overview
  • 7.6. Opto Circuits India Limited
    • 7.6.1. Company Overview
  • 7.7. Schiller AG
    • 7.7.1. Company Overview
  • 7.8. Mortara Instrument, Inc.
    • 7.8.1. Company Overview
  • 7.9. Nihon Kohden Corporation
    • 7.9.1. Company Overview
  • 7.10. Fukuda Denshi Co., Ltd.
    • 7.10.1. Company Overview

8. Cardiovascular Monitoring and Diagnostic Devices Market Pipeline Products

9. Recent Developments

  • 9.1. Corporate Communications
    • 9.1.1. Apr 08, 2014: Ventripoint Corporate Update and Resignation of Director
    • 9.1.2. Feb 12, 2014: ICU Medical Names Vivek Jain as New Chief Executive Officer and Chairman
    • 9.1.3. Jan 31, 2014: AMAG Pharmaceuticals Announces Issuance of New U.S. Patent for Ferumoxytol
    • 9.1.4. Dec 19, 2013: Bioheart Reports Update on CEO
    • 9.1.5. Nov 22, 2013: Voyage Care Acquires Ingleby Care
    • 9.1.6. Nov 18, 2013: Bioheart's President/CEO Mike Tomas Named Chair of the eMerge Innovate Advisory Board of eMerge Americas
    • 9.1.7. Oct 21, 2013: ICU Medical Announces Management Transition
    • 9.1.8. Sep 23, 2013: Bioheart Boosts Team with Regulatory, Finance and Administrative Expertise Three New Key Positions Added
    • 9.1.9. Sep 19, 2013: Atherotech Diagnostics Lab Bolsters Research Efforts with Addition of Abate as Chief Clinical Officer
    • 9.1.10. Sep 19, 2013: IMRIS Announces Addition of Dr. Vipul Patel to SYMBIS Advisory Board
    • 9.1.11. Sep 13, 2013: Arrhythmia Research Technology Announces Resignation of CFO and Appointment of New Principal Financial Officer
    • 9.1.12. Aug 28, 2013: Sheldon T. Anderson Elected to the Board of Directors of Bioheart, Inc.
    • 9.1.13. Aug 15, 2013: R. Stephen Armstrong Joins IMRIS Board of Directors
    • 9.1.14. Aug 01, 2013: CardioNet Holding Company Structure Effective
    • 9.1.15. Jul 29, 2013: Jay D. Miller Appointed Chief Executive Officer
    • 9.1.16. Jul 23, 2013: Vincent Caponi Joins Welch Allyn Board of Directors
    • 9.1.17. Jun 04, 2013: Cheetah Medical Appoints Chris Hutchison As CEO
  • 9.2. Financial Announcements
    • 9.2.1. May 06, 2014: ICU Medical Announces First Quarter 2014 Results
    • 9.2.2. Apr 16, 2014: Osteoarthritis Study shows ActiPatch Therapy Significantly Relieves Knee Pain
    • 9.2.3. Mar 27, 2014: Vasomedical Announces Financial Results for Fourth Quarter and Full Year for 2013
    • 9.2.4. Mar 04, 2014: IMRIS Reports Fourth Quarter and Annual 2011 Financial Results
    • 9.2.5. Feb 12, 2014: ICU Medical Announces Fourth Quarter and Fiscal Year 2013 Results
    • 9.2.6. Jan 20, 2014: Pulmonary Embolism Trial Comparing Endovascular Ultrasound to Standard of Care Anticoagulation Published in the American Heart Association's Journal, Circulation
    • 9.2.7. Nov 19, 2013: Arrhythmia Research Technology Announces Third Quarter 2013 Results
    • 9.2.8. Nov 14, 2013: Vasomedical Recorded 33% Year-over-year Growth in Revenue for the Third Quarter of 2013
    • 9.2.9. Nov 05, 2013: Vasomedical to Report Third Quarter 2013 Results on November 14, 2013
    • 9.2.10. Nov 05, 2013: BioTelemetry Reports Third Quarter 2013 Financial Results
    • 9.2.11. Nov 04, 2013: IMRIS Reports Third Quarter 2013 Financial Results
    • 9.2.12. Oct 29, 2013: BioTelemetry to Release Third Quarter 2013 Earnings Results on November 5, 2013
    • 9.2.13. Oct 21, 2013: ICU Medical Reports Third Quarter 2013 Results
    • 9.2.14. Oct 16, 2013: ICU Medical Announces Time of Third Quarter 2013 Earnings Call
    • 9.2.15. Oct 08, 2013: Arrhythmia Research Technology Announces Second Quarter 2013 Results
    • 9.2.16. Oct 02, 2013: Arrhythmia Research Technology Announces Updated Preliminary Second Quarter Results
    • 9.2.17. Aug 20, 2013: First Databank Acquires Design Clinicals, Medication Reconciliation Solutions Provider
    • 9.2.18. Aug 20, 2013: Arrhythmia Research Technology, Inc. Announces Delay in Finalizing Second Quarter Results
    • 9.2.19. Aug 13, 2013: IMRIS reports second quarter 2013 financial results
    • 9.2.20. Aug 13, 2013: Vasomedical Announces Financial Results for the Second Quarter of 2013
    • 9.2.21. Aug 06, 2013: Vasomedical to Report Second Quarter 2013 Results on August 13, 2013
    • 9.2.22. Jul 30, 2013: CardioNet Reports Second Quarter 2013 Financial Results
    • 9.2.23. Jul 23, 2013: CardioNet to Release Second Quarter 2013 Earnings Results on July 30, 2013
    • 9.2.24. Jul 18, 2013: ICU Medical Reports Second Quarter 2013 Results
    • 9.2.25. Jun 28, 2013: Arrhythmia Research Technology, Inc. Announces First Quarter 2013 Results
    • 9.2.26. Jun 17, 2013: Takeda Announces Availability Of Nesina In US Pharmacies
    • 9.2.27. Jun 03, 2013: Arrhythmia Reports Revenue Of $20.6m In 2012
    • 9.2.28. May 15, 2013: Vasomedical Reports Revenue Of $7.3m In Q1 2013
    • 9.2.29. May 09, 2013: Bioheart Reports Q1 2013 Results
  • 9.3. Government and Public Interest
    • 9.3.1. Jan 06, 2014: ICU Medical to Present at the 32nd Annual J.P. Morgan Healthcare Conference
    • 9.3.2. Jan 02, 2014: Topera to Present at the 32nd Annual J.P. Morgan Healthcare Conference
    • 9.3.3. Dec 31, 2013: Bioheart to Present at Vail Symposium's Winter Program on Cell Therapy
    • 9.3.4. Dec 02, 2013: ZOLL Summit 2014 Call for Presentations
    • 9.3.5. Nov 25, 2013: Topera to Present at the 25th Annual Piper Jaffray Health Conference
    • 9.3.6. Nov 21, 2013: ICU Medical to Present at the Piper Jaffray 25th Annual Healthcare Conference
    • 9.3.7. Nov 13, 2013: IMRIS to present at Investor Healthcare Conferences in New York
    • 9.3.8. Oct 23, 2013: Additional dedicated trainer hospital established in the USA
    • 9.3.9. Aug 09, 2013: IMRIS CEO Jay D. Miller to present at Canaccord Genuity 33rd Annual Global Growth Conference
  • 9.4. Legal And Regulatory
    • 9.4.1. Apr 17, 2014: Boston Heart Granted New York Laboratory Permit for Diagnostic Testing
  • 9.5. Other Significant Developments
    • 9.5.1. Feb 24, 2014: AliveCor Offers Integration With Practice Fusion's Electronic Health Records Platform
    • 9.5.2. Feb 20, 2014: Boston Heart Diagnostics Awarded $1.0 Million in Tax Incentives from the Massachusetts Life Sciences Center
    • 9.5.3. Jan 02, 2014: Response Biomedical Provides Update on Chinese Distribution Agreement with O&D Biotech
    • 9.5.4. Dec 04, 2013: BioTelemetry, Inc. Announces Reduction to Medicare Reimbursement for Remote Cardiac Monitoring Services
    • 9.5.5. Dec 02, 2013: Bioheart Announces Agreement With StemMD to Provide Bioheart Therapies to Its Network
    • 9.5.6. Nov 18, 2013: AliveCor transforms Heart Monitor into eHealth Service
    • 9.5.7. Nov 15, 2013: Millar Appointed Exclusive US Distributor of CD Leycom INCA Pressure-Volume Loop System
    • 9.5.8. Oct 25, 2013: Bioheart Announces Agreement With Anosis to Distribute Products in the Middle East
    • 9.5.9. Oct 16, 2013: Bioheart Announces Contract With African-Middle East Medical to Begin Distributing Stem Cell Products in Uganda
    • 9.5.10. Oct 09, 2013: $2 Million Awarded to Sutter Health, IBM and Geisinger Health System to Study Heart Failure Prediction
    • 9.5.11. Aug 23, 2013: Arrhythmia Research Technology Receives NYSE MKT LLC Exchange Compliance Notice
    • 9.5.12. Jul 09, 2013: Behrman Capital Portfolio Company Atherotech Completes Recapitalization
  • 9.6. Product News
    • 9.6.1. Apr 16, 2014: AtCor Medical Receives Patent in USA
    • 9.6.2. Mar 27, 2014: First Patients Enrolled in Medtronic Clinical Study Designed to Identify Patients at High Risk for Sudden Cardiac Arrest in Developing Countries
    • 9.6.3. Mar 17, 2014: Vasomedical Announces Biox's MobiCare Wireless Patient Monitors Receives Marketing Approval in China
    • 9.6.4. Feb 13, 2014: New Data Support Use of iRhythm's ZIO Service to Identify Cardiac Arrhythmias in Stroke and TIA Patients
    • 9.6.5. Jan 22, 2014: UCLA researchers develop risk calculator to predict survival in heart failure patients
    • 9.6.6. Jan 06, 2014: FDA Reclassifies ECP Devices for Refractory Angina as Class II
    • 9.6.7. Jan 02, 2014: ZIO Service Identifies Significantly More Cardiac Arrhythmias Than the Traditional Holter Monitor, According to Study Published Online in the American Journal of Medicine
    • 9.6.8. Nov 25, 2013: Independent Multi-Center Clinical Study Shows the Use of Topera's 3D Mapping System Improved Long-Term Outcomes for Atrial Fibrillation Patients
    • 9.6.9. Nov 18, 2013: AliveCor Transforms Heart Monitor into eHealth Service
    • 9.6.10. Oct 10, 2013: CardioComm Solutions' HeartCheck Technologies to be used in Canadian Clinical Arrhythmia Risk Screening and Stoke Prevention Trial
    • 9.6.11. Oct 07, 2013: MDxHealth's Prostate Cancer Test Meets Endpoints In DOCUMENT Trial
    • 9.6.12. Aug 23, 2013: AliveCor Launches New Feature to Enhance Visual Quality of ECG
    • 9.6.13. May 14, 2013: iCardiac Releases StudyView Module for iClinica 4G Cardiac Safety Software Platform
  • 9.7. Research And Development
    • 9.7.1. Jun 04, 2013: Immunicum's Intuvax Is Registered As Brand In EU At Office for Harmonization in the Internal Market
  • 9.8. Strategy And Business Planning
    • 9.8.1. Nov 25, 2013: Bioheart Announces New Clinical Site in Mexico
    • 9.8.2. Nov 06, 2013: Welch Allyn Establishes New Regional Headquarters, Operations Center in The Netherlands
    • 9.8.3. Nov 04, 2013: Bioheart Announces Agreement With Global Stem Cell Group to Provide Bioheart Therapies and Training
    • 9.8.4. Jul 25, 2013: First Injection of Dotarem in US Performed at Cincinnati Children's Hospital Medical Center
    • 9.8.5. Jul 02, 2013: Apogenix Strengthens Patent Position for Apocept In Europe And Canada

10. Appendix

  • 10.1. Research Methodology
    • 10.1.1. Coverage
    • 10.1.2. Secondary Research
    • 10.1.3. Primary Research
    • 10.1.4. Market Modeling and Forecasting
    • 10.1.5. Company Share Analysis
    • 10.1.6. Distribution Share Analysis
  • 10.2. Expert Panel
  • 10.3. GlobalData Consulting
  • 10.4. Contact Us
  • 10.5. Disclaimer

List of Tables

  • Table 1: Cardiovascular Monitoring and Diagnostic Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2005-2020
  • Table 2: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Category Comparison by Revenue ($m), USD Constant, 2005-2020
  • Table 3: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Revenue ($m), Historic, USD Constant, 2005-2012
  • Table 4: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Revenue ($m), Forecast, USD Constant, 2012-2020
  • Table 5: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Volume (Units), 2005-2020
  • Table 6: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Volume (Units), Historic, 2005-2012
  • Table 7: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Volume (Units), Forecast, 2012-2020
  • Table 8: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 9: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 10: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 11: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Volume (Units), Historic, 2005-2012
  • Table 12: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Volume (Units), Forecast, 2012-2020
  • Table 13: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Average Price ($), Historic, 2005-2012
  • Table 14: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Average Price ($), Forecast, 2012-2020
  • Table 15: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2011-2012
  • Table 16: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 17: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 18: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 19: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Volume (Units), Historic, 2005-2012
  • Table 20: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Volume (Units), Forecast, 2012-2020
  • Table 21: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Average Price ($), Historic, 2005-2012
  • Table 22: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Average Price ($), Forecast, 2012-2020
  • Table 23: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2011-2012
  • Table 24: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 25: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 26: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 27: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), Historic, 2005-2012
  • Table 28: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), Forecast, 2012-2020
  • Table 29: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Average Price ($), Historic, 2005-2012
  • Table 30: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Average Price ($), Forecast, 2012-2020
  • Table 31: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012
  • Table 32: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 33: Cardiovascular Monitoring and Diagnostic Devices Market Pipeline Products
  • Table 34 Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country

List of Figures

  • Figure 1: Cardiovascular Monitoring and Diagnostic Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2005-2020
  • Figure 2: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Category Comparison by Revenue ($m), USD Constant, 2005-2020
  • Figure 3: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Revenue ($m), Historic, USD Constant, 2005-2012
  • Figure 4: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Revenue ($m), Forecast, USD Constant, 2012-2020
  • Figure 5: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Volume (Units), 2005-2020
  • Figure 6: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Volume (Units), Historic, 2005-2012
  • Figure 7: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Volume (Units), Forecast, 2012-2020
  • Figure 8: Cardiovascular Monitoring and Diagnostic Devices Market, North America, Company Share (%), 2012
  • Figure 9: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 10: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 11: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Volume (Units), Historic, 2005-2012
  • Figure 12: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Volume (Units), Forecast, 2012-2020
  • Figure 13: Cardiovascular Monitoring and Diagnostic Devices Market, Canada, Company Share (%), 2012
  • Figure 14: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 15: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 16: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Volume (Units), Historic, 2005-2012
  • Figure 17: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Volume (Units), Forecast, 2012-2020
  • Figure 18: Cardiovascular Monitoring and Diagnostic Devices Market, Mexico, Company Share (%), 2012
  • Figure 19: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 20: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 21: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), Historic, 2005-2012
  • Figure 22: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), Forecast, 2012-2020
  • Figure 23: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Company Share (%), 2012
  • Figure 24: GlobalData Epidemiology-Based Forecasting Model
  • Figure 25: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 26: Primary Interviews by Participant Type (%)
Back to Top